Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Allopurinol Safety Study Evaluating Outcomes in Gout Patients (LASSO)
2011-002453-65Phase 4Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- Aug 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of allopurinol in gout and hyperuricemia, sponsored by Ardea Biosciences, Inc. Primary endpoint: Incidence of treatment-emergent adverse events. Started Aug 2011; status: completed.
02
Drugs
allopurinol
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on 2011-002453-65.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002453-65.